Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
05/2014
05/28/2014CN102333526B 包含作为令人不愉快味道的掩蔽剂的甜菊苷的快速溶解口服膜剂 Stevia contains, as an unpleasant taste masking agent glycosides fast dissolving oral agent
05/28/2014CN102311442B 具有抗肿瘤活性的螺内酰胺生物碱化合物及其制备方法与应用 Lo lactam alkaloid compound and its preparation method and application has anti-tumor activity
05/28/2014CN102285979B N-(2-(取代苯并噻唑-2-氨基甲酰基)-苯基)-取代吡唑甲酰胺类化合物及其制备方法和用途 N- (2- (substituted benzothiazole-2-carbamoyl) - phenyl) - substituted pyrazole carboxamides and their preparation and use
05/28/2014CN102264742B 3-(3-嘧啶-2-基苄基)-1,2,4-三唑并[4,3-b]哒嗪衍生物 3- (3-pyrimidin-2-yl) -1,2,4-triazolo [4,3-b] pyridazine derivatives
05/28/2014CN102260308B 左旋异戊酰螺旋霉素iii、其制剂、制备方法及应用 L isovaleryloxy spiramycin iii, its preparation, preparation method and application
05/28/2014CN102247396B 左旋可利霉素、其药物组合物、制备方法及应用 L Currie neomycin, pharmaceutical compositions thereof, preparation method and application
05/28/2014CN102247355B 几内亚胡椒碱的抗肿瘤用途 Guinea piperine antitumor use
05/28/2014CN102239162B 哒嗪酮衍生物 Pyridazinones
05/28/2014CN102229634B 左旋异戊酰螺旋霉素i、其制剂、制备方法及应用 L isovaleryloxy spiramycin i, its preparation, preparation method and application
05/28/2014CN102227429B 作为趋化因子受体调节剂的3-氨基环戊烷羧酰胺 As chemokine receptor modulators of 3-amino-cyclopentane-carboxamide
05/28/2014CN102159208B 6-1h-咪唑-1-基喹唑啉和喹啉衍生物、新的mao抑制剂和咪唑啉受体配体 6-1h- imidazol-1-yl-quinoline and quinazoline derivatives, the new mao inhibitors and imidazoline receptor ligand
05/28/2014CN102099474B 用于治疗炎症和赘生性细胞增殖的寡核苷酸 For the treatment of inflammatory and neoplastic cell proliferation oligonucleotide
05/28/2014CN102085199B 治疗类风湿性关节炎的透皮吸收生物贴剂及其制备方法 Biological treatment of rheumatoid arthritis transdermal patch and its preparation method
05/28/2014CN102083429B Ido抑制剂 Ido inhibitor
05/28/2014CN102078305B 苯达莫司汀冻干药物组合物 Bendamustine lyophilized pharmaceutical composition
05/28/2014CN102060844B 一种法舒地尔的晶型Ⅳ及其制备方法和用途 One kind of fasudil crystal type Ⅳ its preparation and use
05/28/2014CN102050814B 达比加群的酯衍生物 Ester derivatives of dabigatran
05/28/2014CN102014632B 吲哚啉抗癌剂 Indoline anticancer
05/28/2014CN102002132B 天然高分子或其水溶性衍生物接枝聚乙烯吡咯烷酮络合碘衍生物的制备方法改进 Preparation of a water-soluble derivative of natural polymer or graft povidone iodine derivatives improve
05/28/2014CN101965345B 吡啶化合物 Pyridine compounds
05/28/2014CN101932325B Ido抑制剂 Ido inhibitor
05/28/2014CN101925596B 用于治疗糖尿病的β-氨基酸衍生物 For the treatment of diabetes β- amino acid derivative
05/28/2014CN101898985B Bcl-2蛋白的N-取代苯磺酰基-取代苯甲酰胺类小分子抑制剂及其应用 N- Bcl-2 protein was substituted phenylsulfonyl - substituted benzamides small molecule inhibitors and their applications
05/28/2014CN101889011B 6,7-二氢-5H-咪唑并[1,2-a]咪唑-3-羧酸酰胺的衍生物 6,7-dihydro -5H- imidazo [1,2-a] imidazole-3-carboxylic acid amide derivative
05/28/2014CN101880217B 一种治疗免疫疾病的药物组合物、其制备及用途 A method of treating autoimmune disease a pharmaceutical composition, its preparation and use
05/28/2014CN101837139B 微生物油 Microbial oil
05/28/2014CN101837138B 微生物油 Microbial oil
05/28/2014CN101837136B 微生物油 Microbial oil
05/28/2014CN101821269B 2-((r)-2-甲基吡咯烷-2-基)-1h-苯并咪唑-4-甲酰胺晶形2 2 - ((r) -2- methyl-pyrrolidin-2-yl) -1h- benzimidazole-4-carboxamide crystalline form 2
05/28/2014CN101810608B 一种靶向于人磷脂酰乙醇胺结合蛋白4的抗肿瘤小分子化合物 A targeted to people phosphatidylethanolamine binding protein antitumor small molecule compounds 4
05/28/2014CN101642452B 脑肿瘤用放射线敏化剂 Brain tumors with a radiation sensitizer
05/28/2014CN101636404B (1r,6s)-2-氮杂双环-[4.3.0]壬烷-8,8-二膦酸及其在治疗和预防骨疾病例如骨质疏松或帕哲氏病方面的用途 (1r, 6s) -2- azabicyclo - [4.3.0] nonane-8,8-diphosphonic acid and the treatment and prevention of bone diseases such as osteoporosis or Paget's disease in the aspects of the use of
05/28/2014CN101558067B 作为mtor抑制剂的2-甲基吗啉吡啶并、吡唑并和嘧啶并-嘧啶衍生物 As mtor inhibitor 2-methyl-morpholine and pyridine, and pyrimidine and pyrazolo - pyrimidine derivatives
05/28/2014CN101535300B Iap bir域结合化合物 Iap bir domain binding compound
05/28/2014CN101378743B 以2-氨基-1,3-丙二醇衍生物为有效成分的炎症性肠疾病治疗剂及其在制备治疗或预防炎症性肠疾病的药物中的用途 2-amino-1,3-propanediol derivative as an active ingredient of a therapeutic agent for inflammatory bowel disease and their use in the manufacture of a medicament for the treatment or prevention of inflammatory bowel disease in
05/28/2014CN101198259B 用于预防和治疗肾脏疾病的方法和组合物 For the prevention and treatment of kidney disease, the methods and compositions
05/28/2014CA2843943A1 Oral formulations of chemotherapeutic agents
05/27/2014US8735633 Methods for making 1,3-dihydroxyacetone (DHA) from glycerol
05/27/2014US8735632 Compounds
05/27/2014US8735604 Pyrrolidines as glucagon receptor antagonists, compositions, and methods for their use
05/27/2014US8735599 Substituted imidazole derivates
05/27/2014US8735595 Acetyl-CoA carboxylase (ACC) inhibitors and their use in diabetes, obesity and metabolic syndrome
05/27/2014US8735593 Aminopyridines useful as inhibitors of protein kinases
05/27/2014US8735585 Indenopyridine derivatives
05/27/2014US8735579 Benzamides, production thereof, and use thereof as medicaments
05/27/2014US8735578 Compounds and pharmaceutical compositions for treating disorders associated with the 5-HT1A and 5-HT2A receptors
05/27/2014US8735570 Cationic dextran polymer derivatives
05/27/2014US8735558 Blocking the migration or metastasis of cancer cells by affecting adhesion proteins and the uses of new compounds thereof
05/27/2014US8735538 Use of methanobactin
05/27/2014US8735453 Lipids, lipid complexes and use thereof
05/27/2014US8735452 Treating patients with intravenous ibuprofen
05/27/2014US8735451 D-serine transporter inhibitors as pharmaceutical compositions for the treatment of visual system disorders
05/27/2014US8735450 Formulation of diclofenac
05/27/2014US8735449 Nitrated-fatty acids modulation of type II diabetes
05/27/2014US8735447 Crystalline solids of a MetAP-2 inhibitor and methods of making and using same
05/27/2014US8735446 Vanillin acetals and sensory stimulant composition containing the same
05/27/2014US8735444 Fluorinated rhodamines as photostable fluorescent dyes for labelling and imaging techniques
05/27/2014US8735443 Method of treating diabetes-related vascular complications
05/27/2014US8735442 Composition for alleviating ultraviolet radiation-induced damage
05/27/2014US8735441 Compounds for enzyme inhibition
05/27/2014US8735440 Methods for treating amyotrophic lateral sclerosis using pro-neurogenic compounds
05/27/2014US8735438 Substituted-aryl-2-phenylethyl-1H-imidazole compounds as subtype selective modulators of alpha 2B and/or alpha 2C adrenergic receptors
05/27/2014US8735437 Imidazolidine carboxamide derivatives as lipase and phospholipase inhibitors
05/27/2014US8735436 Polyunsaturated fatty acids for the treatment of diseases related to cardiovascular, metabolic and inflammatory disease areas
05/27/2014US8735435 CETP inhibitors
05/27/2014US8735434 Compounds as cannabinoid receptor ligands
05/27/2014US8735433 Aryl oxadiazole derivatives as sphingosine 1-phosphate (S1P) receptor modulators
05/27/2014US8735432 N-(Heteroaryl)-1-heteroarylalky1-1H-indole-2-carboxamide derivatives, preparation and therapeutic use thereof
05/27/2014US8735429 Benzamide compounds useful as histone deacetylase inhibitors
05/27/2014US8735428 Methods for treating multiple myeloma with 4-(amino)-2-(2,6-dioxo(3-piperidyl))-isoindoline-1,3-dione
05/27/2014US8735427 Grease-like gel for repelling rodents
05/27/2014US8735426 Vanilloid receptor ligands, pharmaceutical compositions containing them, process for making them and use thereof for treating pain and other conditions
05/27/2014US8735425 Tetrahydroisoquinoline derivative
05/27/2014US8735424 Bicyclic kinase inhibitors
05/27/2014US8735423 Bicyclic compounds as α4β2 nicotinic acetylcholine receptor ligands
05/27/2014US8735422 Cationic pharmaceutically active ingredient containing composition, and methods for manufacturing and using
05/27/2014US8735421 Imidazoquinolinyl sulfonamides
05/27/2014US8735420 Polymorphic forms of naltrexone
05/27/2014US8735419 Forms of rifaximin and uses thereof
05/27/2014US8735418 Pyrimidine-2-amine compounds and their use as inhibitors of JAK kinases
05/27/2014US8735417 Aminopyrimidines as Syk inhibitors
05/27/2014US8735416 Antiviral therapies
05/27/2014US8735415 Acid addition salts of (3,5-Bis trifluoromethyl)-N-[4-methyl-3-(4-pyridin-3yl-pyrimidin-2ylamino)-phenyl]-benzamide
05/27/2014US8735414 Indole derivatives and methods for antiviral treatment
05/27/2014US8735413 Compound
05/27/2014US8735412 Sulfoximine-substituted anilinopyrimidine derivatives as CDK inhibitors, the production thereof, and use as medicine
05/27/2014US8735411 Macrocyclic benzofused pyrimidine derivatives
05/27/2014US8735410 Quinazoline derivatives as tyrosine kinase inhibitors
05/27/2014US8735409 Quinazoline derivatives
05/27/2014US8735408 Solid forms of 3-(4-(aminomethyl)-1-(5-methyl-7H-pyrrolo[2,3-d]pyrimidin-4-yl)piperidine-4-carboxamido)phenyl dimethylcarbamate
05/27/2014US8735407 Purine derivatives as A3 adenosine receptor-selective agonists
05/27/2014US8735406 8-oxodihydropurine derivative
05/27/2014US8735405 6,6-bicyclic ring substituted heterobicyclic protein kinase inhibitors
05/27/2014US8735404 Inhibitors of Bruton's tyrosine kinase
05/27/2014US8735403 Inhibitors of Bruton's tyrosine kinase
05/27/2014US8735402 Cycloalkyloxycarboxylic acid derivatives
05/27/2014US8735401 Thienopyrimidine compounds and use thereof
05/27/2014US8735399 Selective subtype alpha 2 adrenergic agents and methods for use thereof
05/27/2014US8735398 Hepatitis C virus inhibitors
05/27/2014US8735397 Method for treating schizophrenia and related diseases
1 ... 256 257 258 259 260 261 262 263 264 265 266 267 268 269 270 271 272 273 274 275 276 ... 7860